Skip to main content
ROVI Subsidiaries
Spain
Germany
France
Italy
Poland
Portugal
United Kingdom
Language
Spanish
Spanish
English
English
English
Español
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Contact
Products
Prescription Pharmaceuticals
Hospital Products
Manufacturing
CDMO
Own product Manufacturing
R&D
Shareholders and Investors
The share
Investor's Calendar
News
Financial and Business Information
CMNV Communications
ESG
Corporate Governance
Telematic assistance access
Prior Registration On-Line Attendance
On-Line Attendance
Sustainability
Responsible governance
Commitment to people
Environmental Commitment
Ethics Channel
Media
FAQS
News
ROVI up to date
Contact
Work with Us
TELEMATIC ASSISTANCE ACCESS
Home
News
ROVI Rating ESG 2020
Fri, 25/09/2020 - 14:25
0 min
Download related document
Select rating
Give ROVI Rating ESG 2020 1/5
Give ROVI Rating ESG 2020 2/5
Give ROVI Rating ESG 2020 3/5
Give ROVI Rating ESG 2020 4/5
Give ROVI Rating ESG 2020 5/5
No votes yet
Related
ROVI will donate a million surgical masks to the Ministry of Health
Since the beginning of the health crisis caused by the expansion of COVID-19, ROVI has been taking measures to ensure the continuity of its...
1 min
26/03/2020
Full Year 2019 results presentation
0 min
26/02/2020
ROVI reports operating revenue growth of 26% and EBITDA growth of 106%
Operating revenue increased by 26% to 381.3 million euros in 2019, mainly driven by the strength of the specialty pharmaceutical...
6 min
26/02/2020
See More
Email
Facebook
Twitter
LinkedIn